Cipla Drug Patent Portfolio
Cipla owns 1 orange book drug protected by 2 US patents Given below is the list of Cipla's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7589106 | Alcohol free formulation of argatroban | 26 Sep, 2027 | Active |
| US7687516 | Alcohol free formulation of argatroban | 26 Sep, 2027 | Active |
Latest Legal Activities on Cipla's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cipla.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 26 Jul, 2021 | US7589106 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Jul, 2021 | US7687516 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Jul, 2021 | US7589106 |
|
Email Notification
Critical
| 26 Jul, 2021 | US7687516 |
|
Correspondence Address Change
Critical
| 23 Jul, 2021 | US7687516 |
|
Correspondence Address Change
Critical
| 23 Jul, 2021 | US7589106 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Jul, 2021 | US7687516 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Feb, 2021 | US7589106 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Sep, 2017 | US7687516 |
|
Email Notification
Critical
| 02 Nov, 2013 | US7687516 |
| Mail-Petition Decision - Granted | 30 Oct, 2013 | US7687516 |
|
Petition Decision - Granted
Critical
| 29 Oct, 2013 | US7687516 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 28 Oct, 2013 | US7687516 |
| Petition Entered | 24 Sep, 2013 | US7687516 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 20 Feb, 2013 | US7589106 |
Cipla's Family Patents
Cipla drugs have patent protection in a total of 5 countries. It has a significant patent presence in the US with 69.2% of its patents being US patents. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Cipla Drug List
Given below is the complete list of Cipla's drugs and the patents protecting them.
1. Argatroban In Sodium Chloride
Argatroban In Sodium Chloride is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7589106 | Alcohol free formulation of argatroban |
26 Sep, 2027
(2 years from now)
| Active |
| US7687516 | Alcohol free formulation of argatroban |
26 Sep, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Argatroban In Sodium Chloride's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List